Not Yet Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm
NCT07224152
NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
Conditions
Locally-Advanced Non-Small Cell Lung Cancer
Interventions
NBTXR3
Updated 2 times since 2025 Last updated: Dec 10, 2025 Started: Apr 30, 2026 Primary completion: Aug 30, 2028 Completion: Aug 30, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07224152, this PHASE1/PHASE2 trial focuses on Locally-Advanced Non-Small Cell Lung Cancer and remains actively recruiting participants. Sponsored by M.D. Anderson Cancer Center, it has been updated 2 times since 2026, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
2 versions recorded-
Jan 2026 — Present [monthly]
Not Yet Recruiting PHASE1/PHASE2
-
Dec 2025 — Jan 2026 [monthly]
Not Yet Recruiting PHASE1/PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- M.D. Anderson Cancer Center
- Nanobiotix
Data source: M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .